Skip to main content

Table 1 Demographic and survival difference between sedated and non-sedated patients

From: Palliative sedation for terminally ill cancer patients in a tertiary cancer center in Shanghai, China

Variables Total Sedated(N = 82) Non-sedated(N = 162) P value
Total 244 82 162 -
Mean age (years) 63 62 63 0.86
Gender (male/female) 125/119 40/42 85/77 0.34
KPS (median) 20 20 30 0.12
Primary tumor site (N/%)     0.60
 Lung cancer 36 12/14.6% 24/14.8%  
 Liver cancer 30 12/14.6% 18/11.1%  
 Breast cancer 26 8/9.8% 18/11.1%  
 Stomach cancer 33 9/11.0% 24/14.8%  
 Colon cancer 22 8/9.8% 14/8.6%  
 Nasopharyngeal cancer 6 2/2.4% 4/2.5%  
 Kidney/Prostate cancer 17 5/6.1% 12/7.4%  
 Pancreas 20 7/8.5% 13/8.0%  
 Gallbladder 9 3/3.7% 6/3.7%  
 Hematological Cancer 4 2/2.4% 2/1.2%  
 Female genital tract cancer 20 8/9.8% 12/7.4%  
 Primary unknown 7 2/2.4% 5/3.1%  
 Others 12 2/2.4% 10/6.2%  
Survival time (days)(mean) (95CI)* 23.54 27.44 (23.2-31.65) 21.56 (18.52-24.59) 0.066
Total Survival time (months)(mean) (95CI )# 25.86 35.65 (26.55-44.75) 20.90 (16.72-25.10) 0.002
  1. * Survival time means the days since administration till death.
  2. # Total Survival time means the months since diagnose till death.